Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Jefferies 2015 Global Healthcare Conference

BOULDER, Colo., May 26, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Jefferies 2015 Global Healthcare Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   


Jefferies 2015 Global Healthcare Conference


Ron Squarer, Chief Executive Officer


Tuesday, June 2, 2015


1:30 p.m. Eastern Time



Array BioPharma.

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to


Tricia Haugeto

Array BioPharma Inc.



To view the original version on PR Newswire, visit:

SOURCE Array BioPharma Inc.